News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
4,932 Results
Type
Article (603)
Company Profile (2)
Press Release (4327)
Section
Business (1339)
Career Advice (11)
Deals (232)
Drug Delivery (6)
Drug Development (1123)
Employer Resources (5)
FDA (153)
Job Trends (213)
News (2680)
Policy (349)
Tag
Academia (31)
Accelerated approval (1)
Adcomms (1)
Allergies (3)
Alliances (536)
ALS (7)
Alzheimer's disease (78)
Antibody-drug conjugate (ADC) (3)
Approvals (146)
Artificial intelligence (9)
Autoimmune disease (3)
Bankruptcy (3)
Best Places to Work (187)
Biosimilars (1)
Brain cancer (2)
Breast cancer (6)
Cancer (53)
Cardiovascular disease (4)
Career advice (12)
CAR-T (4)
Cell therapy (17)
Clinical research (888)
Collaboration (22)
Compensation (2)
Complete response letters (1)
COVID-19 (103)
C-suite (13)
Data (67)
Depression (1)
Diabetes (2)
Diagnostics (27)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (10)
Drug pricing (11)
Drug shortages (1)
Duchenne muscular dystrophy (14)
Earnings (298)
Editorial (1)
Employer branding (2)
Employer resources (4)
Events (670)
Executive appointments (9)
FDA (173)
Frontotemporal dementia (2)
Funding (14)
Generative AI (2)
Gene therapy (16)
GLP-1 (15)
Government (85)
Guidances (5)
Healthcare (134)
HIV (3)
IgA nephropathy (1)
Immunology and inflammation (6)
Infectious disease (113)
Inflammatory bowel disease (2)
Inflation Reduction Act (3)
Influenza (4)
Intellectual property (1)
IPO (107)
IRA (5)
Job creations (27)
Job search strategy (10)
Labor market (2)
Layoffs (12)
Leadership (2)
Legal (31)
Liver cancer (4)
Lung cancer (6)
Lymphoma (8)
Machine learning (1)
Management (1)
Manufacturing (11)
MASH (1)
Medical device (20)
Medtech (20)
Mergers & acquisitions (140)
Metabolic disorders (9)
Multiple sclerosis (2)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (107)
NextGen: Class of 2026 (50)
Non-profit (44)
Obesity (5)
Opinion (17)
Ovarian cancer (1)
Pain (4)
Parkinson's disease (6)
Patents (4)
Patient recruitment (6)
Peanut (2)
People (469)
Pharmaceutical (4)
Phase 1 (245)
Phase 2 (432)
Phase 3 (369)
Pipeline (42)
Policy (9)
Postmarket research (13)
Preclinical (83)
Press Release (1)
Prostate cancer (1)
Psychedelics (1)
Radiopharmaceuticals (3)
Rare diseases (16)
Real estate (22)
Recruiting (2)
Regulatory (292)
Reports (1)
Research institute (31)
RSV (5)
Schizophrenia (2)
Series A (3)
Spinal muscular atrophy (14)
Startups (38)
Stomach cancer (1)
Supply chain (3)
Tariffs (1)
The Weekly (1)
Vaccines (21)
Venture capital (1)
Weight loss (3)
Date
Last 7 days (8)
Last 30 days (16)
Last 365 days (275)
2026 (24)
2025 (283)
2024 (355)
2023 (427)
2022 (698)
2021 (636)
2020 (572)
2019 (406)
2018 (213)
2017 (276)
2016 (230)
2015 (248)
2014 (87)
2013 (69)
2012 (77)
2011 (79)
2010 (65)
Location
Africa (9)
Asia (447)
Australia (32)
California (70)
Canada (22)
China (8)
Colorado (1)
Connecticut (28)
Delaware (14)
Europe (1381)
Florida (2)
Illinois (4)
India (1)
Japan (3)
Maryland (35)
Massachusetts (54)
Minnesota (1)
New Jersey (19)
New York (30)
North Carolina (6)
Northern California (22)
Ohio (5)
Pennsylvania (15)
South America (8)
Southern California (41)
Texas (2)
United States (285)
Utah (1)
Virginia (2)
Washington D.C. (2)
Washington State (3)
4,932 Results for "CURE_Pharma_".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Opinion
Pharma Is Sitting on Hidden Cures. Find Your “Freda” To Unlock Them
Had Pfizer’s Freda Lewis-Hall not stepped in, SpringWorks’ rare disease treatment may never have reached patients. Pharmas can act now to help find the next Gomekli.
November 4, 2025
·
4 min read
·
Annette Bakker
Press Releases
Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV
November 13, 2024
·
2 min read
Pharm Country
Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced results from two studies of RADICAVA® (edaravone) for amyotrophic lateral sclerosis (ALS) at the European Network to Cure Amyotrophic Lateral Sclerosis (ENCALS) 2024 meeting.
June 17, 2024
·
8 min read
Press Releases
AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam
February 2, 2026
·
3 min read
Press Releases
AlzeCure Abstract on NeuroRestore ACD856 accepted at the Alzheimer’s conference AP/PD 2026
February 3, 2026
·
7 min read
Pharm Country
AscellaHealth Presents Drug Reimbursement Strategies for 21st Century Cures: IDN & Bio/Pharma Partnering Summit
AscellaHealth, a global specialty pharmacy and healthcare solutions company, announces that it will present “Drug Reimbursement Strategies for 21st Century Cures” at the IDN and Bio/Pharma Partnering Summit, Aug. 19, 11:15 a.m.–12 p.m. EDT.
August 10, 2021
·
2 min read
Infectious disease
GSK, Ionis Achieve Functional Cure in Hepatitis B Studies, Clearing Path for FDA Run
Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.
January 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
NMDP Appoints Ginna Laport, MD, to New Senior Physician Leadership Role
February 12, 2026
·
3 min read
Press Releases
AlzeCure Receives Payment of EU Grant for Phase 2 Clinical Trial with NeuroRestore ACD856 for Alzheimer’s Disease
December 3, 2025
·
6 min read
Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023
Ascletis Pharma Inc. announces that Dr. Jinzi J. Wu, Founder, Chairman and CEO of Ascletis was invited to attend and have a presentation at the 10th International Workshop on HBV Cure 2023 held at Boston, United States.
November 8, 2023
·
4 min read
1 of 494
Next
